Free Trial

AstraZeneca (AZN) Dividend Yield, Date & History

AstraZeneca logo
£102.22 -22.00 (-0.21%)
(As of 12/20/2024 12:31 PM ET)

AstraZeneca Dividend Summary

Dividend Yield
2.29%
Annual Dividend
GBX 234
Recent
Dividend Payment
Sep. 9
Dividend Payout Ratio
7,428.57%

AstraZeneca (AZN) pays an annual dividend of GBX 234 per share, with a dividend yield of 2.29%. The next payment of GBX 77.60 per share was paid on Monday, September 9, to investors who owned the stock before the ex-dividend date of Thursday, August 8. The company currently pays out 7,428.57% of its earnings and 89.03% of its cash flow as dividends.

Get Dividend Stock Ideas Daily

Enter your email address below to receive the DividendStocks.com newsletter, a daily email that contains dividend stock ideas, ex-dividend stocks, and the latest dividend investing news.

Sign Up
Skip Charts & View Dividend History

AZN Dividend Payments by Quarter

The chart below displays up to four years of AstraZeneca's dividend payment history by quarter. The blue bars represent historical dividend payments, while the gray bars indicate future payments.

AZN Dividend Yield Over Time

The chart below tracks AstraZeneca's dividend yield over the past four years. The line represents changes in yield by quarter, providing a clear view of trends over time.

AstraZeneca vs. The Competition

Compare AstraZeneca's annual dividend, yield, and 3-year growth rate with averages for Medical and LON companies to evaluate its performance against the market.

TypeAstraZenecaMedical CompaniesLON Companies
Annual DividendGBX 234GBX 0.06GBX 26.65
Dividend Yield2.29%5.09%5.45%

AstraZeneca Dividend Payout Ratio

Dividend payout ratios express the dividend as a percentage of another metric, such as earnings or cash flow, and can be used to assess dividend sustainability.

TypePayout Ratio
Based on Trailing 12 Months of Earnings7,428.57%
Based on This Year's Estimate32.07%
Based on Cashflow89.03%

AstraZeneca Dividend History by Quarter

AnnouncedPeriodPaymentPayment ChangeYieldEx-Dividend DateRecord DatePayable Date
7/25/2024GBX 77.60-GBX 78.40
50.26%
0.64%8/8/20248/8/20249/9/2024
2/8/2024GBX 156+GBX 84.20
117.27%
1.49%2/22/20242/22/20243/25/2024
7/28/2023GBX 71.80-GBX 91
55.90%
0.67%8/10/20238/10/20239/11/2023
Cackling Kamala hates this company (Ad)

Do you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution.

Before that happens, you need to see the details here.
2/9/2023GBX 162.80+GBX 86.40
113.09%
1.51%2/23/20232/23/20233/27/2023

This table shows AstraZeneca's dividend history, including payout amounts, yield, dividend changes, and key dates. Use the date filter to explore data as far back as 2013 to analyze trends over time.

AstraZeneca Dividend - Frequently Asked Questions

The current dividend yield for AstraZeneca is 2.29%. Learn more on AZN's dividend yield history.

The annual dividend for AZN shares is GBX 234. Learn more on AZN's annual dividend history.

AstraZeneca's most recent dividend payment of GBX 77.60 per share was made to shareholders on Monday, September 9, 2024.

AstraZeneca's most recent ex-dividend date was Thursday, August 8, 2024.

The most recent change in the company's dividend was a decrease of GBX 78.40 on Thursday, July 25, 2024.

The dividend payout ratio for AZN is:
  • 7,428.57% based on the trailing year of earnings
  • 32.07% based on this year's estimates
  • 89.03% based on cash flow

AstraZeneca's dividend yield of 1.97% is lower than the average Medical company that issues a dividend. AstraZeneca's dividend payout ratio of 7,428.57% may not be sustainable.

Looking at the stock as a whole, market analysts rate AstraZeneca stock as a Moderate Buy, forecasting growth opportunities and potential value appreciation.


This page (LON:AZN) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners